SP-420
SP-420 Basic information
- Product Name:
- SP-420
- Synonyms:
-
- SP-420
- (4S)-4,5-Dihydro-2-[2-hydroxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl]-4-methyl-4-thiazolecarboxylic acid
- SP420;SP 420
- CS-2097
- 4-Thiazolecarboxylic acid, 4,5-dihydro-2-[2-hydroxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl]-4-methyl-, (4S)-
- (2E,4S)-2-[4-[2-(2-methoxyethoxy)ethoxy]-6-oxocyclohexa-2,4-dien-1-ylidene]-4-methyl-1,3-thiazolidine-4-carboxylic acid
- SP420,SP-420,Inhibitor,inhibit
- (S)-2-(2-Hydroxy-4-(2-(2-methoxyethoxy)ethoxy)phenyl)-4-methyl-4,5-dihydrothiazole-4-carboxylic acid
- CAS:
- 911714-45-9
- MF:
- C16H21NO6S
- MW:
- 355.41
- Mol File:
- 911714-45-9.mol
SP-420 Chemical Properties
- Melting point:
- 82-83℃ (ethyl acetate hexane )
- Boiling point:
- 562.2±60.0 °C(Predicted)
- Density
- 1.32±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMF: 10mg/mL; DMSO: 15mg/mL; Ethanol: 15mg/mL; Ethanol:PBS (pH 7.2) (1:4): 0.2mg/mL
- form
- A crystalline solid
- pka
- 1.02±0.40(Predicted)
- color
- Light yellow to khaki
SP-420 Usage And Synthesis
Description
SP 420 is an iron chelator and a derivative of desferrothiocin. It induces iron excretion in rat bile and urine with an iron-clearing efficiency (ICE) value of 26.7% when administered at a dose of 300 μmol/kg and decreases iron levels in rat liver and heart at 384 μmol/kg per day. SP 420 (75 μmol/kg) also induces iron excretion in iron-overloaded C. apella monkeys (ICE = 26.3%).
Uses
Petadeferitrin is a tridentate iron chelator belonging to the class of iron chelators, with oral activity. Petadeferitrin can be used in research related to β-thalassemia[1][2][3].
in vivo
Petadeferitrin causes renal function abnormalities, including increased serum creatinine, proteinuria, increased urine protein/creatinine ratio, and glycosuria[3].
References
[1] Bergeron RJ, et al. Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles. J Med Chem. 2012 Aug 23;55(16):7090-103. DOI:10.1021/jm300509y
[2] Basu S, et al. Understanding the intricacies of iron overload associated with β-thalassemia: a comprehensive review[J]. Thalassemia Reports, 2023, 13(3): 179-194.
[3] Taher A T, et al. Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemia[J]. American Journal of Hematology, 2017, 92(12): 1356-1361. DOI:10.1002/ajh.24914
SP-420Supplier
- Tel
- sales@boylechem.com
- Tel
- 021-58950125
- info@chemexpress.com
- Tel
- Mobile:13665161512
- Tel
- 025-58849295 18951903616;
- info@adooq.cn
- Tel
- +86 (21) 61124340